EU drug regulator reviewing woman's death in Belgium after getting J&J shot

LONDON - The European Union's drug regulator said on Wednesday it is reviewing the death of a woman in

Belgium who suffered a blood clot and low platelets after receiving Johnson & Johnson's COVID-19 vaccine, the first report of a fatality following the vaccine. The European Medicines Agency (EMA) said it has asked the U.S. drugmaker to carry out a series of additional studies to help assess a possible link between the shot and a rare clotting condition known as thrombosis with thrombocytopenia syndrome (TTS).